Effect of treatment on serum brain–derived neurotrophic factor levels in depressed patients
- 633 Downloads
Researchers have reported that serum brain–derived neurotrophic factor (sBDNF) of drug–free depressed patients are lower than those of healthy controls and proposed that low sBDNF levels might reflect failure of neuronal plasticity in depression. In this study, we compared sBDNF levels of depressed patients (n = 28) before and after 8 weeks of antidepressant treatment, with those of healthy controls (n = 18) to test the hypothesis that initially low sBDNF levels of drug–free depressed patients will increase parallel with their clinical response to antidepressant treatment. The severity of depression and response to treatment were assessed with Hamilton Rating Scale for Depression (HAM–D). sBDNF was assayed with the sandwich ELISA method. Baseline sBDNF levels of patients (mean, 20.8 ng/ml; [S.D., 6.7]) were significantly lower than those of controls (mean, 26.8 ng/ml; [S.D., 9.3]; p = 0.015), and were negatively correlated with HAM–D scores (r = –0.49, p = 0.007). After 8 weeks of treatment, sBDNF levels of patients had increased significantly (mean, 33.3 ng/ml; [S.D., 9.9]; p < 0.001) and no longer differed from those of controls. These results support the hypothesis that BDNF might play a critical role in the pathophysiology of major depressive disorder and successful antidepressant treatment increases the attenuated BDNF levels in depressed patients.
Key wordsantidepressants biological marker brain–derived neurotrophic factor (BDNF) major depression neuroplasticity
Unable to display preview. Download preview PDF.
- 1.American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th ed. American Psychiatric Press, Washington, DCGoogle Scholar
- 3.Bianchi M, Moser C, Lazzarini C, Vecchiato E, Crespi F (2002) Forced swimming test and fluoxetine treatment, in vivo evidence that peripheral 5-HT in rat platelet-rich plasma mirrors cerebral extracellular 5-HT levels, whilst 5-HT in isolated platelets mirrors neuronal 5-HT changes. Exp Brain Res 143:191–197PubMedCrossRefGoogle Scholar
- 22.Markstein R, Matsumoto M, Kohler C, Togashi H, Yoshioka M, Hoyer D (1999) Pharmacological characterisation of 5-HT receptors positively coupled to adenylyl cyclase in the rat hippocampus. Naunyn Schmiedebergs Arch Pharmacol 359:454–459Google Scholar
- 36.Shelton RC (2000) Cellular mechanisms in the vulnerability to depression and response to antidepressants. Psychiatric Clin North Am 23:713–29Google Scholar
- 38.Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C, Nakazato M, Watanabe H, Shinoda N, Okada S, Iyo M (2003) Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients without or with antidepressants. Biol Psychiatry 54:70–75PubMedCrossRefGoogle Scholar
- 42.Spitzer M (1999) Neuroplasticity. In: The Mind Within The Net, Massachusetts, Cambridge: The MIT Press, pp 137–168Google Scholar